These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 29777582

  • 1. Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.
    Li Y, Zheng J, Shen Y, Li W, Liu M, Wang J, Zhu S, Wu M.
    Med Sci Monit; 2018 May 19; 24():3293-3300. PubMed ID: 29777582
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X, Qi J, Yu D, Wu Y, Zhu S, Li S, Wu Q, Ren G, Li D.
    J Diabetes Complications; 2017 Apr 19; 31(4):726-734. PubMed ID: 28143735
    [Abstract] [Full Text] [Related]

  • 3. A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2).
    Nomoto H, Miyoshi H, Furumoto T, Oba K, Tsutsui H, Miyoshi A, Kondo T, Tsuchida K, Atsumi T, Manda N, Kurihara Y, Aoki S, SAIS Study Group.
    PLoS One; 2015 Apr 19; 10(8):e0135854. PubMed ID: 26284918
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
    Tamura K, Minami K, Kudo M, Iemoto K, Takahashi H, Seino S.
    PLoS One; 2015 Apr 19; 10(5):e0126003. PubMed ID: 25938469
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glutamine up-regulates pancreatic sodium-dependent neutral aminoacid transporter-2 and mitigates islets apoptosis in diabetic rats.
    Medras ZJH, El-Sayed NM, Zaitone SA, Toraih EA, Sami MM, Moustafa YM.
    Pharmacol Rep; 2018 Apr 19; 70(2):233-242. PubMed ID: 29475006
    [Abstract] [Full Text] [Related]

  • 10. Liraglutide prevents fast weight gain and β-cell dysfunction in male catch-up growth rats.
    Zheng J, Chen T, Zhu Y, Li HQ, Deng XL, Wang QH, Zhang JY, Chen LL.
    Exp Biol Med (Maywood); 2015 Sep 19; 240(9):1165-76. PubMed ID: 25710926
    [Abstract] [Full Text] [Related]

  • 11. Liraglutide and sitagliptin counter beta- to alpha-cell transdifferentiation in diabetes.
    Tanday N, Flatt PR, Irwin N, Moffett RC.
    J Endocrinol; 2020 Apr 19; 245(1):53-64. PubMed ID: 31977315
    [Abstract] [Full Text] [Related]

  • 12. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD, Lavery KS, Irwin N, O'harte FP, Harriott P, Greer B, Bailey CJ, Flatt PR.
    J Pharmacol Exp Ther; 2006 Aug 19; 318(2):914-21. PubMed ID: 16648370
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
    Fosgerau K, Jessen L, Lind Tolborg J, Østerlund T, Schæffer Larsen K, Rolsted K, Brorson M, Jelsing J, Skovlund Ryge Neerup T.
    Diabetes Obes Metab; 2013 Jan 19; 15(1):62-71. PubMed ID: 22862961
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.